NetworkNewsBreaks

ThursdayOct 05, 2023 12:13 pm

NetworkNewsBreaks – DoubleDown Interactive Co. Ltd. (NASDAQ: DDI) Announces ACS Donation, ‘Spin for a Cure’ Event

DoubleDown Interactive (NASDAQ: DDI), a leading developer and publisher of digital games on mobile and web-based platforms, today announced a planned donation of $10,000 to the American Cancer Society (“ACS”) in honor of Breast Cancer Awareness Month. According to the update, DoubleDown Casino, which is played daily by millions of fans worldwide on both desktop and mobile devices, will invite players to engage with and show support for the charitable donation by taking part in a play-to-enter giveaway on Oct. 11, 2023. The “Spin for a Cure” event offers players the chance to express their enthusiasm for helping the American…

Continue Reading

ThursdayOct 05, 2023 12:07 pm

NetworkNewsBreaks — Longeveron Inc. (NASDAQ: LGVN; LGVNR) Reports Top-Line Results for Phase 2a Lomecel-B Clinical Trial

Longeveron (NASDAQ: LGVN; LGVNR), a clinical-stage biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions such as hypoplastic left heart syndrome (“HLHS”), Alzheimer’s disease and Aging-Related Frailty, has released top-line results for its phase 2a trial of its investigational product Lomecel-B(TM). The study evaluated Lomecel-B for the treatment of mild Alzheimer’s disease. According to the report, the primary endpoint of safety was met across all study groups; in addition, the secondary endpoint of change from baseline to week 39 in Composite Alzheimer’s Disease Score (“CADS”) also demonstrated positive results. The report also noted that other doses demonstrated numerical…

Continue Reading

ThursdayOct 05, 2023 11:46 am

NetworkNewsBreaks – Clene Inc. (NASDAQ: CLNN) Announces $45.1M NINDS Grant to Support Expanded Access Protocol for CNM-Au8(R) in ALS

Clene (NASDAQ: CLNN), through its wholly owned subsidiary Clene Nanomedicine Inc. in collaboration with Columbia University and Synapticure, was awarded a four-year grant totaling $45.1 million from the National Institute of Neurological Disorders and Stroke (“NINDS”), a division of the National Institutes of Health (“NIH”). The grant is to support an Expanded Access Protocol (“EAP”) for the company’s investigational drug, CNM-Au8(R), in amyotrophic lateral sclerosis (“ALS”). Also referred to as Compassionate Use, an EAP is an FDA-regulated pathway that allows people with a serious and life-threatening disease to access an investigational drug that is not yet approved by the U.S.…

Continue Reading

ThursdayOct 05, 2023 10:55 am

NetworkNewsBreaks – FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) UNBUZZD Definitive Agreement Featured by Investment Pitch Media

FSD Pharma (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, has entered into a definitive agreement with Celly Nutrition Corp. According to the announcement, the Oct. 4, 2023, agreement outlines the distribution of a portion of FSD Pharma's shareholdings of Celly Nu to certain securityholders of FSD Pharma. The company noted that it has scheduled a virtual meeting on Nov. 20, 2023, for FSD Pharma securityholders to consider and vote on a special resolution approving the agreement, or plan of arrangement. A prerevenue, early-stage research and development company,…

Continue Reading

ThursdayOct 05, 2023 9:50 am

NetworkNewsBreaks – Bruush Oral Care Inc. (NASDAQ: BRSH) Enters into Private Placement Expected to Reach $5M

Bruush Oral Care (NASDAQ: BRSH), a company committed to inspiring confidence through brighter smiles and better oral health, has entered into a securities purchase agreement with an institutional investor. The company anticipates the purchase agreement to total an estimated $5 million in gross proceeds before deducting standard fees and other offering expenses. According to the announcement, the company plans to issue 79,724 common shares, a prefunded common share purchase warrant to purchase 7,181,146 common shares, and a common share purchase warrant to purchase 8,350,000 common shares — all as part of the private placement. The company noted that the common…

Continue Reading

WednesdayOct 04, 2023 3:25 pm

NetworkNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Deploys K5 ASR, K1 Hemisphere for New Contracts in Southern California

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots and blue light emergency communication systems, has announced two new contracts from a Los Angeles area shopping center and a medical clinic. The announcement reads, “The Knightscope K5 Autonomous Security Robot (‘ASR’) will be patrolling the interior of a large, cultural mall in the Los Angeles area. Shopping centers are places where people go to shop, dine, relax, browse or meet in a fun and safe atmosphere. Providing that safe environment reduces vacancies, mitigates risk, elevates property values and increases foot traffic. Knightscope ASRs have already successfully deterred substance abuse,…

Continue Reading

WednesdayOct 04, 2023 3:01 pm

NetworkNewsBreaks – Estrella Immunopharma Inc. (NASDAQ: ESLA, ESLAW) Starts Trading After TradeUP Acquisition Corp., Estrella Biopharma Inc. Business Combination

Estrella Immunopharma (NASDAQ: ESLA, ESLAW), formerly known as TradeUP Acquisition Corp. (“UPTD”), has successful closed a business combination with Estrella Biopharma Inc. Estrella Biopharma is a preclinical-stage biopharmaceutical company focused on developing T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. According to the announcement, shares in the combined company — Estrella Immunopharma — began trading on Oct. 2, 2023; in addition, all remaining UPTD units will separate into their underlying components, consisting of one share of combined company's common stock and one-half of one warrant. The combined company brings together capital and a…

Continue Reading

WednesdayOct 04, 2023 2:54 pm

NetworkNewsBreaks – Astra Energy Inc. (ASRE), SETI Partnership to Provide Near-Continuous Energy Generation Capability

Astra Energy (OTCQB: ASRE), a renewable and waste-to-energy project developer and technology acquisition company, has announced a strategic collaboration with Sustainable Energy Technologies Inc. (“SETI”). According to the announcement, SETI will provide Astra with its proprietary SETI Power Pack (“SPP”), a next-generation energy-storage solution. A hybrid graphene/lithium-ion supercapacitor, the SPP is designed for use instead of traditional batteries. When the Holcomb Energy Systems (“HES”) In-Line Power Generator (“ILPG”) and the HES Self-Sustaining Power Plant utilize the SETI Power Packs, they offer near-continuous energy generation capability. The partnership enables both companies to provide an essential component to delivering a first-in-class energy…

Continue Reading

WednesdayOct 04, 2023 2:47 pm

NetworkNewsBreaks – Santo Mining Corp. (SANP), Planta Vida S.A.S. Enter Strategic Joint Venture

Santo (OTC: SANP), a vertically integrated 4th industrial revolution firm specializing in end-to-end blockchain-as-a-service (“BaaS”) solutions and other cutting-edge technologies such as IoT, AI, NFTs, and data analytics, has announced its entry into a strategic joint venture agreement with Planta Vida S.A.S. According to the announcement, the company will outline the business operations of this agreement during the days and weeks to come. “This agreement gives us, for the first time, a true sold partnership with a group that is highly skilled and respected in the cannabis industry,” said Frank Yglesias, CEO of Santo. “This will allow us to focus…

Continue Reading

WednesdayOct 04, 2023 2:29 pm

NetworkNewsBreaks – FingerMotion Inc. (NASDAQ: FNGR) Issues Response to Short Seller Report

FingerMotion (NASDAQ: FNGR), a mobile services and data company, is responding to the Oct. 3, 2023, short seller report issued by Capybara Research, a short-selling research firm. According to the statement, FingerMotion management reviewed the report and believe that the report contains errors, unsupported speculations and inaccurate interpretations of events; management and the company’s board of directors are planning further review and examination of allegations and misinformation contained in the report. The company “will take whatever necessary and appropriate actions may be required to protect the interest of its shareholders,” the announcement stated. “The company is already in the process…

Continue Reading